Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Agios Pharmaceuticals, Inc. (AGIO)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Agios Pharmaceuticals, Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1439222.
Total stock buying since 2015: $225,626,257.
Total stock sales since 2015: $157,286,004.
Total stock option exercises since 2015: $24,780,238.
Table 3. Detailed insider trading at Agios Pharmaceuticals, Inc. (AGIO) , Part 3
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2018-11-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 70.36 | 211,089 |
| 2018-11-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-10-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 70.21 | 210,636 |
| 2018-10-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-09-28 | Alenson Carman (Principal Accounting Officer) | Sale | 152 | 76.45 | 11,620 |
| 2018-09-12 | Maraganore John (Director) | Sale | 14,162 | 71.74 | 1,015,981 |
| 2018-09-11 | Maraganore John (Director) | Sale | 13,555 | 73.17 | 991,819 |
| 2018-09-10 | Schenkein David P (Chief Executive Officer) | Option Ex | 8,730 | 31.64 | 276,217 |
| 2018-09-05 | Alenson Carman (Principal Accounting Officer) | Sale | 312 | 83.00 | 25,896 |
| 2018-09-05 | Alenson Carman (Principal Accounting Officer) | Option Ex | 312 | 52.29 | 16,314 |
| 2018-09-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 83.36 | 250,071 |
| 2018-09-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-09-05 | Schenkein David P (Chief Executive Officer) | Option Ex | 75,119 | 16.99 | 1,276,271 |
| 2018-08-30 | Bowden Christopher (Chief Medical Officer) | Sale | 1,700 | 80.03 | 136,051 |
| 2018-08-30 | Bowden Christopher (Chief Medical Officer) | Option Ex | 1,700 | 35.16 | 59,771 |
| 2018-08-29 | Bowden Christopher (Chief Medical Officer) | Sale | 300 | 80.00 | 24,000 |
| 2018-08-29 | Bowden Christopher (Chief Medical Officer) | Option Ex | 300 | 35.16 | 10,547 |
| 2018-08-24 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 2,050 | 74.92 | 153,586 |
| 2018-08-24 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-08-06 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 79.78 | 239,340 |
| 2018-08-06 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-07-25 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 2,050 | 84.58 | 173,389 |
| 2018-07-25 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-07-10 | Bowden Christopher (Chief Medical Officer) | Sale | 2,000 | 86.84 | 173,680 |
| 2018-07-10 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,000 | 35.16 | 70,320 |
| 2018-07-09 | Alenson Carman (Principal Accounting Officer) | Sale | 272 | 84.94 | 23,103 |
| 2018-07-09 | Alenson Carman (Principal Accounting Officer) | Option Ex | 272 | 52.29 | 14,222 |
| 2018-07-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 83.86 | 251,594 |
| 2018-07-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-06-22 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 2,050 | 97.58 | 200,039 |
| 2018-06-22 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-06-14 | Foster-cheek Kaye I (Director) | Sale | 9,000 | 93.57 | 842,102 |
| 2018-06-14 | Foster-cheek Kaye I (Director) | Option Ex | 9,000 | 50.73 | 456,570 |
| 2018-06-12 | Bowden Christopher (Chief Medical Officer) | Sale | 2,000 | 93.11 | 186,210 |
| 2018-06-12 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,000 | 35.16 | 70,320 |
| 2018-06-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 93.33 | 279,999 |
| 2018-06-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-06-01 | Schenkein David P (Chief Executive Officer) | Sale | 13,000 | 95.70 | 1,244,061 |
| 2018-06-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 13,000 | 1.40 | 18,252 |
| 2018-05-30 | Schenkein David P (Chief Executive Officer) | Sale | 45,626 | 90.07 | 4,109,533 |
| 2018-05-30 | Schenkein David P (Chief Executive Officer) | Option Ex | 45,626 | .36 | 16,334 |
| 2018-05-23 | Biller Scott (Chief Scientific Officer) | Sale | 15,177 | 90.00 | 1,365,930 |
| 2018-05-23 | Biller Scott (Chief Scientific Officer) | Option Ex | 15,177 | 31.64 | 480,200 |
| 2018-05-23 | Schenkein David P (Chief Executive Officer) | Sale | 49,374 | 91.25 | 4,505,229 |
| 2018-05-23 | Schenkein David P (Chief Executive Officer) | Option Ex | 49,374 | .30 | 14,960 |
| 2018-05-23 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 2,050 | 85.76 | 175,808 |
| 2018-05-23 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-05-08 | Bowden Christopher (Chief Medical Officer) | Sale | 2,000 | 81.38 | 162,760 |
| 2018-05-08 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,000 | 35.16 | 70,320 |
| 2018-05-07 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 81.81 | 245,430 |
| 2018-05-07 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-05-01 | Schenkein David P (Chief Executive Officer) | Sale | 13,000 | 83.60 | 1,086,761 |
| 2018-05-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 13,000 | .30 | 3,939 |
| 2018-04-23 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 2,050 | 85.95 | 176,197 |
| 2018-04-23 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-04-12 | Bowden Christopher (Chief Medical Officer) | Sale | 2,000 | 85.23 | 170,460 |
| 2018-04-12 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,000 | 35.16 | 70,320 |
| 2018-04-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 75.57 | 226,709 |
| 2018-04-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-04-02 | Schenkein David P (Chief Executive Officer) | Sale | 13,000 | 77.56 | 1,008,228 |
| 2018-04-02 | Schenkein David P (Chief Executive Officer) | Option Ex | 13,000 | .30 | 3,939 |
| 2018-03-28 | Biller Scott (Chief Scientific Officer) | Option Ex | 4,137 | 1.40 | 5,808 |
| 2018-03-22 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 2,050 | 84.65 | 173,532 |
| 2018-03-22 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-03-19 | Foster-cheek Kaye I (Director) | Sale | 6,800 | 81.97 | 557,396 |
| 2018-03-19 | Foster-cheek Kaye I (Director) | Option Ex | 6,800 | 47.33 | 321,844 |
| 2018-03-16 | Scadden David (Director) | Buy | 200 | 83.44 | 16,688 |
| 2018-03-14 | Bowden Christopher (Chief Medical Officer) | Sale | 2,000 | 82.56 | 165,130 |
| 2018-03-14 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,000 | 35.16 | 70,320 |
| 2018-03-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 82.57 | 247,709 |
| 2018-03-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 9.05 | 27,150 |
| 2018-03-01 | Schenkein David P (Chief Executive Officer) | Sale | 13,000 | 80.84 | 1,050,920 |
| 2018-03-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 13,000 | .30 | 3,939 |
| 2018-02-26 | Foster-cheek Kaye I (Director) | Option Ex | 2,200 | 47.33 | 104,126 |
| 2018-02-22 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 2,050 | 78.63 | 161,191 |
| 2018-02-22 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-02-16 | Bowden Christopher (Chief Medical Officer) | Sale | 2,000 | 77.80 | 155,590 |
| 2018-02-16 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,000 | 35.16 | 70,320 |
| 2018-02-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 76.34 | 229,035 |
| 2018-02-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 4.76 | 14,277 |
| 2018-02-01 | Bowden Christopher (Chief Medical Officer) | Sale | 2,000 | 78.86 | 157,730 |
| 2018-02-01 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,000 | 35.16 | 70,320 |
| 2018-02-01 | Schenkein David P (Chief Executive Officer) | Sale | 13,000 | 78.86 | 1,025,244 |
| 2018-02-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 13,000 | .30 | 3,939 |
| 2018-01-26 | Schenkein David P (Chief Executive Officer) | Sale | 23,572 | 81.32 | 1,916,945 |
| 2018-01-26 | Schenkein David P (Chief Executive Officer) | Option Ex | 23,572 | .30 | 7,142 |
| 2018-01-24 | Schenkein David P (Chief Executive Officer) | Sale | 13,553 | 80.01 | 1,084,375 |
| 2018-01-24 | Schenkein David P (Chief Executive Officer) | Option Ex | 13,553 | .30 | 4,106 |
| 2018-01-23 | Schenkein David P (Chief Executive Officer) | Sale | 32,875 | 80.01 | 2,630,328 |
| 2018-01-23 | Schenkein David P (Chief Executive Officer) | Option Ex | 32,875 | .30 | 9,961 |
| 2018-01-23 | Celgene European Investment Co Llc (10% Owner) | Buy | 851,154 | 67.00 | 57,027,318 |
| 2018-01-23 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 25,000 | 74.83 | 1,870,750 |
| 2018-01-23 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 25,000 | 39.76 | 994,000 |
| 2018-01-16 | Schenkein David P (Chief Executive Officer) | Sale | 53,000 | 73.42 | 3,891,525 |
| 2018-01-16 | Schenkein David P (Chief Executive Officer) | Option Ex | 53,000 | .30 | 16,059 |
| 2018-01-12 | Alenson Carman (Principal Accounting Officer) | Sale | 2,150 | 75.00 | 161,250 |
| 2018-01-12 | Alenson Carman (Principal Accounting Officer) | Option Ex | 2,150 | 52.29 | 112,423 |
| 2018-01-10 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 65.00 | 195,000 |
| 2018-01-10 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | .47 | 1,404 |
| 2017-12-07 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,838 | 60.06 | 110,399 |
| 2017-12-06 | Biller Scott (Chief Scientific Officer) | Option Ex | 46,795 | 1.09 | 51,053 |
| 2017-12-06 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 58.95 | 117,906 |
| 2017-12-01 | Biller Scott (Chief Scientific Officer) | Sale | 2,146 | 60.76 | 130,390 |
| 2017-12-01 | Biller Scott (Chief Scientific Officer) | Option Ex | 2,146 | 31.64 | 67,899 |
| 2017-12-01 | Schenkein David P (Chief Executive Officer) | Sale | 6,000 | 61.80 | 370,770 |
| 2017-12-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 6,000 | .30 | 1,818 |
| 2017-11-14 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 59.91 | 119,820 |
| 2017-11-13 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 62.07 | 124,140 |
| 2017-11-01 | Biller Scott (Chief Scientific Officer) | Sale | 2,146 | 63.49 | 136,255 |
| 2017-11-01 | Biller Scott (Chief Scientific Officer) | Option Ex | 2,146 | 31.64 | 67,899 |
| 2017-11-01 | Schenkein David P (Chief Executive Officer) | Sale | 6,000 | 65.03 | 390,198 |
| 2017-11-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 6,000 | .30 | 1,818 |
| 2017-10-17 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 71.10 | 142,200 |
| 2017-10-16 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 71.09 | 142,180 |
| 2017-10-04 | Biller Scott (Chief Scientific Officer) | Sale | 10,470 | 70.00 | 732,900 |
| 2017-10-04 | Schenkein David P (Chief Executive Officer) | Sale | 80,000 | 70.14 | 5,611,200 |
| 2017-10-04 | Schenkein David P (Chief Executive Officer) | Option Ex | 80,000 | .30 | 24,240 |
| 2017-10-02 | Schenkein David P (Chief Executive Officer) | Sale | 6,000 | 66.76 | 400,560 |
| 2017-10-02 | Schenkein David P (Chief Executive Officer) | Option Ex | 6,000 | .30 | 1,818 |
| 2017-09-18 | Schenkein David P (Chief Executive Officer) | Sale | 35,000 | 67.12 | 2,349,200 |
| 2017-09-18 | Schenkein David P (Chief Executive Officer) | Option Ex | 35,000 | .30 | 10,605 |
| 2017-09-14 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 65.71 | 131,420 |
| 2017-09-13 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 65.47 | 130,940 |
| 2017-09-11 | Bowden Christopher (Chief Medical Officer) | Sale | 6,000 | 65.00 | 390,000 |
| 2017-09-11 | Bowden Christopher (Chief Medical Officer) | Option Ex | 6,000 | 35.16 | 210,959 |
| 2017-09-11 | Biller Scott (Chief Scientific Officer) | Sale | 15,000 | 65.00 | 975,000 |
| 2017-09-01 | Biller Scott (Chief Scientific Officer) | Sale | 2,146 | 61.99 | 133,030 |
| 2017-09-01 | Biller Scott (Chief Scientific Officer) | Option Ex | 2,146 | 9.05 | 19,421 |
| 2017-09-01 | Schenkein David P (Chief Executive Officer) | Sale | 6,000 | 62.20 | 373,200 |
| 2017-09-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 6,000 | .30 | 1,818 |
| 2017-08-23 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 57.08 | 114,160 |
| 2017-08-22 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 56.62 | 113,240 |
| 2017-08-02 | Biller Scott (Chief Scientific Officer) | Sale | 21,000 | 60.06 | 1,261,260 |
| 2017-08-02 | Schenkein David P (Chief Executive Officer) | Sale | 24,000 | 60.55 | 1,453,200 |
| 2017-08-02 | Schenkein David P (Chief Executive Officer) | Option Ex | 24,000 | .30 | 7,272 |
| 2017-08-01 | Biller Scott (Chief Scientific Officer) | Sale | 2,146 | 55.05 | 118,137 |
| 2017-08-01 | Biller Scott (Chief Scientific Officer) | Option Ex | 2,146 | 9.05 | 19,421 |
| 2017-08-01 | Schenkein David P (Chief Executive Officer) | Sale | 3,000 | 55.12 | 165,360 |
| 2017-08-01 | Schenkein David P (Chief Executive Officer) | Option Ex | 3,000 | .30 | 909 |
| 2017-07-20 | Cantley Lewis Clayton Jr. (Director) | Sale | 2,000 | 57.12 | 114,250 |
| 2017-07-19 | Cantley Lewis Clayton Jr. (Director) | Sale | 7,000 | 56.13 | 392,910 |
| 2017-07-07 | Biller Scott (Chief Scientific Officer) | Sale | 2,146 | 55.00 | 118,030 |
| 2017-07-07 | Biller Scott (Chief Scientific Officer) | Option Ex | 2,146 | 9.05 | 19,421 |
| 2017-07-03 | Schenkein David P (Chief Executive Officer) | Sale | 3,000 | 51.18 | 153,540 |
| 2017-07-03 | Schenkein David P (Chief Executive Officer) | Option Ex | 3,000 | .30 | 909 |
| 2017-06-23 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | .47 | 1,404 |
| 2017-06-21 | Biller Scott (Chief Scientific Officer) | Sale | 4,292 | 55.00 | 236,060 |
| 2017-06-21 | Biller Scott (Chief Scientific Officer) | Option Ex | 7,292 | 4.76 | 34,702 |
| 2017-06-14 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,000 | 51.09 | 51,090 |
| 2017-06-13 | Cantley Lewis Clayton Jr. (Director) | Sale | 1,000 | 50.64 | 50,640 |
Insider trading activities including stock purchases, stock sales, and option exercises
of AGIO listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Agios Pharmaceuticals, Inc. (symbol AGIO,
CIK number 1439222) see
the Securities and Exchange Commission (SEC) website.